PATENT CLAIM ANALYSIS

Application Number: 16184903
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["514", "597000"]

Abstract:
The present disclosure relates to the use of celiprolol or a pharmaceutically acceptable salt thereof for treating vascular Ehlers-Danlos syndrome in women during pregnancy and peripartum period.

Claim (Index 16):
A method for treating vascular Ehlers-Danlos syndrome in a woman in need thereof, the method comprising continuing administration of celiprolol or a pharmaceutically acceptable salt without dose adjustment to a woman who has been treated with celiprolol or a pharmaceutically acceptable salt, and who may become pregnant or is confirmed of being pregnant.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13373145', '12453756', '13066914', '15129771', '14261057']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7334163533223815
- 35 USC 102 Novelty (BERT): 0.5103430701156808
- Combined Prediction Score: 0.7111090250017115
- Mean Citation Score: 201.469168
- Max Citation Score: 211.40631
- Similarity Product: 117.30605801395475

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test